RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xenon Pharmaceuticals Stock

Xenon Pharmaceuticals ROA 2024

Xenon Pharmaceuticals ROA

-0.19

Ticker

XENE

ISIN

CA98420N1050

WKN

A12ETN

In 2024, Xenon Pharmaceuticals's return on assets (ROA) was -0.19, a 14.1% increase from the -0.17 ROA in the previous year.

Xenon Pharmaceuticals Aktienanalyse

What does Xenon Pharmaceuticals do?

Xenon Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of innovative therapies for rare diseases. It was founded in 1996 and is headquartered in Burnaby, British Columbia, Canada, with additional offices in the United States and Europe. The company has become a leading biotech company in the industry and focuses on identifying and developing treatments for rare diseases through its proprietary platform called Extreme Genetics. Xenon Pharmaceuticals has a wide pipeline of clinical candidates targeting diseases such as ichthyosis, X-linked adrenoleukodystrophy, pain disorders, and epilepsy. It collaborates with pharmaceutical companies to utilize its platform technology and expertise in the research of rare diseases. Its key drug candidate is XEN496 for the treatment of epilepsy. Overall, Xenon Pharmaceuticals plays a significant role in the biotech industry and continues to make progress in developing innovative therapies for rare diseases. Xenon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Xenon Pharmaceuticals's Return on Assets (ROA)

Xenon Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Xenon Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Xenon Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Xenon Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Xenon Pharmaceuticals stock

What is the Return on Assets (ROA) of Xenon Pharmaceuticals this year?

The Return on Assets (ROA) of Xenon Pharmaceuticals is -0.19 undefined this year.

What was the ROA of Xenon Pharmaceuticals compared to the previous year?

The ROA of Xenon Pharmaceuticals has increased by 14.1% compared to the previous year.

What consequences do high ROA have for investors of Xenon Pharmaceuticals?

A high ROA is advantageous for investors of Xenon Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Xenon Pharmaceuticals?

A low ROA can be unfavorable for investors of Xenon Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Xenon Pharmaceuticals affect the company?

An increase in ROA of Xenon Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Xenon Pharmaceuticals impact the company?

A reduction in the ROA of Xenon Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Xenon Pharmaceuticals?

Some factors that can influence the ROA of Xenon Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Xenon Pharmaceuticals important for investors?

The ROA of Xenon Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Xenon Pharmaceuticals take to improve ROA?

To improve ROA, Xenon Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Xenon Pharmaceuticals pay?

Over the past 12 months, Xenon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xenon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Xenon Pharmaceuticals?

The current dividend yield of Xenon Pharmaceuticals is .

When does Xenon Pharmaceuticals pay dividends?

Xenon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xenon Pharmaceuticals?

Xenon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Xenon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xenon Pharmaceuticals located?

Xenon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xenon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xenon Pharmaceuticals from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Xenon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of Xenon Pharmaceuticals in the year 2023?

In the year 2023, Xenon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Xenon Pharmaceuticals pay out the dividend?

The dividends of Xenon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Xenon Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Xenon Pharmaceuticals

Our stock analysis for Xenon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xenon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.